|
WO2020093069A1
|
|
Management of risk of cation overload and electrolyte imbalance with topically applied buffers
|
|
WO2020086766A1
|
|
Methods and formulations for transdermal administration of dermal contouring agents
|
|
WO2020073033A1
|
|
Formulations and methods for transdermal administration of ketones
|
|
WO2020073030A1
|
|
Iron formulations for topical administration and methods of treatment of iron deficiency
|
|
US10842758B1
|
|
Transdermal penetrant formulations containing cannabidiol
|
|
US2019201327A1
|
|
Topical applications of withaferin a
|
|
WO2019055884A2
|
|
Inhibition of spontaneous metastasis via protein inhibitors of cysteine proteases
|
|
WO2019055880A2
|
|
Method of administration and treatment
|
|
US2018369387A1
|
|
Transdermal carrier
|
|
AU2017209524A1
|
|
Enhanced transdermal delivery of active agents
|
